跳至主要内容
临床试验/ITMCTR2100004908
ITMCTR2100004908已完成未知

Effect of modified Yiqi Huoxue therapy on patients with heart failure with preserved ejection fraction

Beijing Hepingli Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • The diagnosis of HFPEF was based on the 2018 Guidelines for the Diagnosis and Treatment of Chronic Heart Failure in China. Main diagnostic criteria:
  • 1. Symptoms: dyspnea, fatigue, edema of lower limbs;
  • 2. Signs: rales in the lungs, tachypnea, swollen jugular vein, enlarged liver;
  • 3. Auxiliary examination: echocardiography revealed enlarged heart, abnormal cardiac function, and elevated plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP). However, the Left Ventricle Eject Fraction (LVEF) >= 50%.

排除标准

  • Patients with hyperthyroidism, renal disease, tumor, recent urinary tract infection, short-term systemic infection, and pregnancy.

研究者

发起方
Beijing Hepingli Hospital

相似试验